For your third month, you can increase your weekly dose to 1 mg
Triple agonists like retatrutide add GIP and glucagon agonism to GLP-1 effects
Members of your family should also know how to use it
Contraindication, MedlinePlus (2023) Highlights of prescribing information, Novo Nordisk (2024) GLP-1 receptor agonists and the risk of thyroid cancer, Diabetes Care (2023) One-year treatment of obesity: A randomized, double-blind, placebo-controlled, multicentre study of orlistat, a gastrointestinal lipase inhibitor, International Journal of Obesity and Related Metabolic Disorders (2000) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice
SeekPeptides members often ask about unexpected side effects like this one, and understanding why your body responds the way it does is the first step toward managing it effectively
One disrupted dose wont derail your treatment